Late Breaking Abstract - Asthma prevalence and management in adults in France in 2018: ASTHMAPOP survey

Authors:

Abstract
Introduction: The latest survey in general population estimating asthma prevalence in France was run in 2006 (Delmas, Rev Mal Respir 2010; 27:151-9). Objectives: Main objectives were to estimate asthma prevalence and distribution of asthmatics according to GINA steps. Secondary objectives were to describe patients, asthma management and burden of disease. Methods: Cross-sectional survey using Kantar-TNS panel of households, representative of the French population. Questionnaire sent by post to 19,676 panellists ≥ 18 years. Data collected between 10/01 - 21/02/2018. Validated questionnaires used for asthma control (ACQ-6), quality of life (EQ-5D-5L) and adherence (MMAS-4). Results: Analysis of 15,587 questionnaires. Asthma prevalence during life: 12.8% (n=1989). Prevalence in the past year: 6.4% (993 asthmatics). Mean age of these asthmatics is 48.2 years, 60.5% female, mean BMI 26.7 kg/m2, median age at diagnosis 19.2 years; 32% reported allergic rhinitis and 19% arterial hypertension. A total of 946 reported having a treatment, 42.6% a daily treatment with ICS, 46.4% had good adherence (MMAS-4 score = 4). Conclusion: Prevalence of current asthma in France is estimated 6.4% in 2018, with a proportion of GINA 5 step of treatment in accordance with previous estimation. Level of control is poor and many asthmatics experience exacerbations, even in GINA 1 treatment. Asthma management in France in 2018 needs improvements. Funded by Astra Zeneca